Multimodal tumor treatment with RT, DTIC and HT in combination with zVAD-fmk increases infiltration of DCs and of CD8+ T cells into lymph nodes and the IFNγ expression by CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.